Shine Lawyers lead Johnson & Johnson talcum powder class action in Australia

• Johnson & Johnson agreed to settle US$5.5bn in ongoing suits against its talc products in the United States.
• The Australian class action proceedings may have different requirements for participation and compensation outcomes compared to the US settlements.
• Shine Lawyers is leading the class action against Johnson & Johnson and its related subsidiaries in Australia.
• The suit alleges that Johnson & Johnson's talcum powder products were defective, unfit for purpose, and not of merchantable quality due to their potential to cause gynaecological cancers or mesothelioma.

Lawyers representing clients who used Johnson & Johnson's talcum powder products should advise their clients to monitor the Australian class action proceedings, as potential compensation outcomes may differ from those in the US settlements.

Johnson & Johnson's talcum powder products have been at the center of numerous lawsuits worldwide, with the company recently agreeing to settle US$5.5bn in ongoing suits against its talc products in the United States. However, this development does not necessarily translate to similar outcomes for Australians affected by these products. In fact, lawyers representing clients who used Johnson & Johnson's talcum powder products are warning that potential compensation outcomes may differ significantly from those in the US settlements. This is because the Australian class action proceedings will be determined by specific circumstances and may have different requirements for participation.

The Shine Lawyers-led class action against Johnson & Johnson and its related subsidiaries was filed on 23 July in the Supreme Court of Victoria. The suit alleges that the company's talcum powder products were defective, unfit for purpose, and not of merchantable quality due to their potential to cause gynaecological cancers or mesothelioma. The class action covers individuals with biological female sex characteristics who were diagnosed with a gynaecological cancer or mesothelioma before 1 December 2025, as well as the executors, administrators, beneficiaries, or trustees of their estates and dependents living or dead.

The potential for differing compensation outcomes in Australia highlights the importance of monitoring the ongoing class action proceedings. Lawyers representing clients who used Johnson & Johnson's talcum powder products should advise their clients to stay informed about the specific circumstances and requirements of the Australian case, as these may differ significantly from those in the US settlements. The Shine Lawyers-led class action is a critical step towards seeking justice for Australians affected by these products.

Lawyers representing clients who used Johnson & Johnson's talcum powder products should advise their clients to monitor the Australian class action proceedings, as potential compensation outcomes may differ from those in the US settlements.

Source: Original reporting via Australasian Lawyer